Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
Gespeichert in:
| Veröffentlicht in: | Immunity (Cambridge, Mass.) Mass.), 2022-09, Vol.55 (9), p.1749-1749 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1749 |
|---|---|
| container_issue | 9 |
| container_start_page | 1749 |
| container_title | Immunity (Cambridge, Mass.) |
| container_volume | 55 |
| creator | Garris, Christopher S. Arlauckas, Sean P. Kohler, Rainer H. Trefny, Marcel P. Garren, Seth Piot, Cécile Engblom, Camilla Pfirschke, Christina Siwicki, Marie Gungabeesoon, Jeremy Freeman, Gordon J. Warren, Sarah E. Ong, SuFey Browning, Erica Twitty, Christopher G. Pierce, Robert H. Le, Mai H. Algazi, Alain P. Daud, Adil I. Pai, Sara I. Zippelius, Alfred Weissleder, Ralph Pittet, Mikael J. |
| description | |
| doi_str_mv | 10.1016/j.immuni.2022.07.021 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2714655970</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2714655970</sourcerecordid><originalsourceid>FETCH-LOGICAL-c260t-47230c342af5ce85be3b10277cce63cab819392f545d7c68d7fdcedf77fda43c3</originalsourceid><addsrcrecordid>eNotkE1OwzAQhS0EEqVwAxZesnHwX-JkWaX8RKoAQVlbruOA28Rp7aRSxbG4B2cioaxmRnrv6c0HwDXBEcEkuV1Html6ZyOKKY2wiDAlJ2BCcCYQJyk-HXfBkUgIOwcXIawxJjzO8AR8vfVamxCqvoYz11n0MkcE5spp42Exprbdp_Fqe4CvZtdbbwJcwtzUNZobV3rbWf13wty3IXSq3sDC7dt6b90HHKwwP3TtxrrBV9w_oZ9vqFwJiwUi9BKcVaoO5up_TsH7_d0yf0SL54ciny2QpgnuEBeUYc04VVWsTRqvDFsRTIUYiidMq1VKMpbRKuZxKXSSlqIqtSkrMUzFmWZTcHPM3fp215vQycYGPXRWzrR9kFQQnsRxJvAg5UepHr_xppJbbxvlD5JgObKWa3lkLUfWEgs5sGa_2nl1jA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2714655970</pqid></control><display><type>article</type><title>Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12</title><source>Cell Press Free Archives</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Garris, Christopher S. ; Arlauckas, Sean P. ; Kohler, Rainer H. ; Trefny, Marcel P. ; Garren, Seth ; Piot, Cécile ; Engblom, Camilla ; Pfirschke, Christina ; Siwicki, Marie ; Gungabeesoon, Jeremy ; Freeman, Gordon J. ; Warren, Sarah E. ; Ong, SuFey ; Browning, Erica ; Twitty, Christopher G. ; Pierce, Robert H. ; Le, Mai H. ; Algazi, Alain P. ; Daud, Adil I. ; Pai, Sara I. ; Zippelius, Alfred ; Weissleder, Ralph ; Pittet, Mikael J.</creator><creatorcontrib>Garris, Christopher S. ; Arlauckas, Sean P. ; Kohler, Rainer H. ; Trefny, Marcel P. ; Garren, Seth ; Piot, Cécile ; Engblom, Camilla ; Pfirschke, Christina ; Siwicki, Marie ; Gungabeesoon, Jeremy ; Freeman, Gordon J. ; Warren, Sarah E. ; Ong, SuFey ; Browning, Erica ; Twitty, Christopher G. ; Pierce, Robert H. ; Le, Mai H. ; Algazi, Alain P. ; Daud, Adil I. ; Pai, Sara I. ; Zippelius, Alfred ; Weissleder, Ralph ; Pittet, Mikael J.</creatorcontrib><identifier>ISSN: 1074-7613</identifier><identifier>EISSN: 1097-4180</identifier><identifier>DOI: 10.1016/j.immuni.2022.07.021</identifier><language>eng</language><ispartof>Immunity (Cambridge, Mass.), 2022-09, Vol.55 (9), p.1749-1749</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c260t-47230c342af5ce85be3b10277cce63cab819392f545d7c68d7fdcedf77fda43c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Garris, Christopher S.</creatorcontrib><creatorcontrib>Arlauckas, Sean P.</creatorcontrib><creatorcontrib>Kohler, Rainer H.</creatorcontrib><creatorcontrib>Trefny, Marcel P.</creatorcontrib><creatorcontrib>Garren, Seth</creatorcontrib><creatorcontrib>Piot, Cécile</creatorcontrib><creatorcontrib>Engblom, Camilla</creatorcontrib><creatorcontrib>Pfirschke, Christina</creatorcontrib><creatorcontrib>Siwicki, Marie</creatorcontrib><creatorcontrib>Gungabeesoon, Jeremy</creatorcontrib><creatorcontrib>Freeman, Gordon J.</creatorcontrib><creatorcontrib>Warren, Sarah E.</creatorcontrib><creatorcontrib>Ong, SuFey</creatorcontrib><creatorcontrib>Browning, Erica</creatorcontrib><creatorcontrib>Twitty, Christopher G.</creatorcontrib><creatorcontrib>Pierce, Robert H.</creatorcontrib><creatorcontrib>Le, Mai H.</creatorcontrib><creatorcontrib>Algazi, Alain P.</creatorcontrib><creatorcontrib>Daud, Adil I.</creatorcontrib><creatorcontrib>Pai, Sara I.</creatorcontrib><creatorcontrib>Zippelius, Alfred</creatorcontrib><creatorcontrib>Weissleder, Ralph</creatorcontrib><creatorcontrib>Pittet, Mikael J.</creatorcontrib><title>Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12</title><title>Immunity (Cambridge, Mass.)</title><issn>1074-7613</issn><issn>1097-4180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNotkE1OwzAQhS0EEqVwAxZesnHwX-JkWaX8RKoAQVlbruOA28Rp7aRSxbG4B2cioaxmRnrv6c0HwDXBEcEkuV1Html6ZyOKKY2wiDAlJ2BCcCYQJyk-HXfBkUgIOwcXIawxJjzO8AR8vfVamxCqvoYz11n0MkcE5spp42Exprbdp_Fqe4CvZtdbbwJcwtzUNZobV3rbWf13wty3IXSq3sDC7dt6b90HHKwwP3TtxrrBV9w_oZ9vqFwJiwUi9BKcVaoO5up_TsH7_d0yf0SL54ciny2QpgnuEBeUYc04VVWsTRqvDFsRTIUYiidMq1VKMpbRKuZxKXSSlqIqtSkrMUzFmWZTcHPM3fp215vQycYGPXRWzrR9kFQQnsRxJvAg5UepHr_xppJbbxvlD5JgObKWa3lkLUfWEgs5sGa_2nl1jA</recordid><startdate>20220913</startdate><enddate>20220913</enddate><creator>Garris, Christopher S.</creator><creator>Arlauckas, Sean P.</creator><creator>Kohler, Rainer H.</creator><creator>Trefny, Marcel P.</creator><creator>Garren, Seth</creator><creator>Piot, Cécile</creator><creator>Engblom, Camilla</creator><creator>Pfirschke, Christina</creator><creator>Siwicki, Marie</creator><creator>Gungabeesoon, Jeremy</creator><creator>Freeman, Gordon J.</creator><creator>Warren, Sarah E.</creator><creator>Ong, SuFey</creator><creator>Browning, Erica</creator><creator>Twitty, Christopher G.</creator><creator>Pierce, Robert H.</creator><creator>Le, Mai H.</creator><creator>Algazi, Alain P.</creator><creator>Daud, Adil I.</creator><creator>Pai, Sara I.</creator><creator>Zippelius, Alfred</creator><creator>Weissleder, Ralph</creator><creator>Pittet, Mikael J.</creator><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220913</creationdate><title>Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12</title><author>Garris, Christopher S. ; Arlauckas, Sean P. ; Kohler, Rainer H. ; Trefny, Marcel P. ; Garren, Seth ; Piot, Cécile ; Engblom, Camilla ; Pfirschke, Christina ; Siwicki, Marie ; Gungabeesoon, Jeremy ; Freeman, Gordon J. ; Warren, Sarah E. ; Ong, SuFey ; Browning, Erica ; Twitty, Christopher G. ; Pierce, Robert H. ; Le, Mai H. ; Algazi, Alain P. ; Daud, Adil I. ; Pai, Sara I. ; Zippelius, Alfred ; Weissleder, Ralph ; Pittet, Mikael J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c260t-47230c342af5ce85be3b10277cce63cab819392f545d7c68d7fdcedf77fda43c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Garris, Christopher S.</creatorcontrib><creatorcontrib>Arlauckas, Sean P.</creatorcontrib><creatorcontrib>Kohler, Rainer H.</creatorcontrib><creatorcontrib>Trefny, Marcel P.</creatorcontrib><creatorcontrib>Garren, Seth</creatorcontrib><creatorcontrib>Piot, Cécile</creatorcontrib><creatorcontrib>Engblom, Camilla</creatorcontrib><creatorcontrib>Pfirschke, Christina</creatorcontrib><creatorcontrib>Siwicki, Marie</creatorcontrib><creatorcontrib>Gungabeesoon, Jeremy</creatorcontrib><creatorcontrib>Freeman, Gordon J.</creatorcontrib><creatorcontrib>Warren, Sarah E.</creatorcontrib><creatorcontrib>Ong, SuFey</creatorcontrib><creatorcontrib>Browning, Erica</creatorcontrib><creatorcontrib>Twitty, Christopher G.</creatorcontrib><creatorcontrib>Pierce, Robert H.</creatorcontrib><creatorcontrib>Le, Mai H.</creatorcontrib><creatorcontrib>Algazi, Alain P.</creatorcontrib><creatorcontrib>Daud, Adil I.</creatorcontrib><creatorcontrib>Pai, Sara I.</creatorcontrib><creatorcontrib>Zippelius, Alfred</creatorcontrib><creatorcontrib>Weissleder, Ralph</creatorcontrib><creatorcontrib>Pittet, Mikael J.</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Immunity (Cambridge, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Garris, Christopher S.</au><au>Arlauckas, Sean P.</au><au>Kohler, Rainer H.</au><au>Trefny, Marcel P.</au><au>Garren, Seth</au><au>Piot, Cécile</au><au>Engblom, Camilla</au><au>Pfirschke, Christina</au><au>Siwicki, Marie</au><au>Gungabeesoon, Jeremy</au><au>Freeman, Gordon J.</au><au>Warren, Sarah E.</au><au>Ong, SuFey</au><au>Browning, Erica</au><au>Twitty, Christopher G.</au><au>Pierce, Robert H.</au><au>Le, Mai H.</au><au>Algazi, Alain P.</au><au>Daud, Adil I.</au><au>Pai, Sara I.</au><au>Zippelius, Alfred</au><au>Weissleder, Ralph</au><au>Pittet, Mikael J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12</atitle><jtitle>Immunity (Cambridge, Mass.)</jtitle><date>2022-09-13</date><risdate>2022</risdate><volume>55</volume><issue>9</issue><spage>1749</spage><epage>1749</epage><pages>1749-1749</pages><issn>1074-7613</issn><eissn>1097-4180</eissn><doi>10.1016/j.immuni.2022.07.021</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1074-7613 |
| ispartof | Immunity (Cambridge, Mass.), 2022-09, Vol.55 (9), p.1749-1749 |
| issn | 1074-7613 1097-4180 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2714655970 |
| source | Cell Press Free Archives; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| title | Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T04%3A25%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Successful%20Anti-PD-1%20Cancer%20Immunotherapy%20Requires%20T%20Cell-Dendritic%20Cell%20Crosstalk%20Involving%20the%20Cytokines%20IFN-%CE%B3%20and%20IL-12&rft.jtitle=Immunity%20(Cambridge,%20Mass.)&rft.au=Garris,%20Christopher%20S.&rft.date=2022-09-13&rft.volume=55&rft.issue=9&rft.spage=1749&rft.epage=1749&rft.pages=1749-1749&rft.issn=1074-7613&rft.eissn=1097-4180&rft_id=info:doi/10.1016/j.immuni.2022.07.021&rft_dat=%3Cproquest_cross%3E2714655970%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2714655970&rft_id=info:pmid/&rfr_iscdi=true |